Clinical Trials Browser

Phase 2 × Diet Therapy × Plasma cell × Clear all

NCT04497961 2025-09-11

A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

Phase 2 Active not recruiting

Multiple Myeloma